SUPN
#1792
Supernus Pharmaceuticals, Inc. - Common Stock
46.6 6 USD
-0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.46%
Variación mensual
+5.83%
Variación en los últimos 6 meses
-7.05%
Cambio anual
-13.59%
Cierres anteriores
47.3 5
Open
46.6 6
Mínimo
46.6 6
High
46.6 6
Volumen
151
Financials
- Market Capitalization 2.71 B
- Employee 778
- Founded 2005
- CEO Jack A. Khattar
- Website www.supernus.com
- Headquarter Delaware, United States
- FIGI BBG000BP0HX7
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-101.35
Relación precio/flujo de caja
3.78
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1358 |  INDV Indivior Pharmaceuticals, Inc. - Common Stock | 40.23 USD | +0.05% | -1.40% | +4.17% | +19.73% | 4.90 B USD | ||
| 1772 |  RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.65 USD | +11.88% | -2.92% | -66.71% | -61.03% | 2.79 B USD | ||
| 1913 |  PBH Prestige Consumer Healthcare Inc. Common Stock | 47.18 USD | -3.50% | -5.34% | +0.17% | -37.49% | 2.24 B USD | ||
| 1998 |  HCM HUTCHMED (China) Limited - American Depositary Shares | 11.25 USD | +0.99% | -0.09% | +6.13% | -32.84% | 1.96 B USD |